---
title: "BIOSAIPH PHARMACEUTICALS INC. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/60deb85a-aed6-5c7c-aede-9af603cbab8b
json: https://whiteintel.dev/api/public/dossier/60deb85a-aed6-5c7c-aede-9af603cbab8b
identifier: icij:icijol-101734596
jurisdiction: BB
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# BIOSAIPH PHARMACEUTICALS INC.

**Type:** Company  
**Jurisdiction:** BB  
**Identifier:** `icij:icijol-101734596`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/60deb85a-aed6-5c7c-aede-9af603cbab8b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/60deb85a-aed6-5c7c-aede-9af603cbab8b  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/101734596

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **BIOSAIPH PHARMACEUTICALS INC.**. Human view: https://whiteintel.dev/entity/60deb85a-aed6-5c7c-aede-9af603cbab8b · Structured JSON: https://whiteintel.dev/api/public/dossier/60deb85a-aed6-5c7c-aede-9af603cbab8b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._